| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,677 |
3,996 |
$467K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,193 |
5,280 |
$435K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,322 |
1,531 |
$145K |
| 76942 |
|
1,073 |
947 |
$73K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
3,903 |
3,285 |
$69K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
439 |
439 |
$62K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,640 |
787 |
$40K |
| 64483 |
|
103 |
101 |
$23K |
| 97162 |
|
277 |
277 |
$23K |
| 97014 |
|
1,589 |
747 |
$21K |
| 76881 |
|
262 |
254 |
$15K |
| 20611 |
|
167 |
119 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
83 |
83 |
$8K |
| 20551 |
|
159 |
146 |
$8K |
| 64484 |
|
25 |
24 |
$4K |
| 20550 |
|
15 |
15 |
$743.21 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
29 |
29 |
$625.77 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
29 |
29 |
$581.10 |